Dr. MartensDOCMF 55 Equity-to-Asset is 0.41 as of Mar. 2026, which is 8% above its 10-year median of 0.38. GuruFocus rates DOCMF with a GF Score™ of 55/100 and a GF Value™ of $0.97 (Fairly Valued). The stock has 3 warning signs investors should review. Among 1,060 Manufacturing - Apparel & Accessories companies, Dr. Martens ranks worse than 69.15% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Dr. Martens's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $482 Mil. Dr. Martens's Total Assets for the quarter that ended in Mar. 2026 was $1,170 Mil.
Therefore, Dr. Martens's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.41.
The historical rank and industry rank for Dr. Martens's Equity-to-Asset or its related term are showing as below:
DOCMF'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.07 Med: 0.38 Max: 0.41
Current: 0.41
During the past 9 years, the highest Equity to Asset Ratio of Dr. Martens was 0.41. The lowest was -0.07. And the median was 0.38.
Dr. Martens (OTCPK:DOCMF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Dr. Martens Equity-to-Asset Related Terms
Dr. Martens Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Dr. Martens's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DOCMF vs NKE, DECK, ONON: Equity-to-Asset Comparison
For the Footwear & Accessories subindustry, Dr. Martens's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr. Martens Equity-to-Asset vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Dr. Martens's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Dr. Martens's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Dr. Martens's Equity to Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr. Martens (DOCMF) has a Equity-to-Asset of 0.41 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Dr. Martens and its competitors. This is near median its historical median of 0.38. According to the industry distribution chart, Dr. Martens ranks #733 out of 1060 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 69.2%.
Is Dr. Martens' Equity-to-Asset too high?
Dr. Martens' current Equity-to-Asset of 0.41 is near median its 10-year median of 0.38. The Manufacturing - Apparel & Accessories industry median Equity-to-Asset is 0.55. Dr. Martens' value of 0.41 is 25.5% below this industry median. Based on the distribution chart, Dr. Martens ranks #733 out of 1060 companies in the Manufacturing - Apparel & Accessories industry, which is below the industry midpoint. Overall, Dr. Martens has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' Equity-to-Asset compare to NKE and DECK?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Dr. Martens ranks #733 out of 1060 companies for Equity-to-Asset. This places Dr. Martens in the lower half of its industry. The industry median Equity-to-Asset is 0.55. Dr. Martens' value of 0.41 is 25.5% below this benchmark. While the company's 10-year median is 0.38 vs. the industry median of 0.55, Dr. Martens has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Manufacturing - Apparel & Accessories company?
The median Equity-to-Asset among Manufacturing - Apparel & Accessories companies is 0.55, based on 1,060 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr. Martens's current Equity-to-Asset of 0.41 is 25.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Dr. Martens and its competitors. For the Manufacturing - Apparel & Accessories industry, the median Equity-to-Asset is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr. Martens's current Equity-to-Asset is 0.41, which is near median its own 10-year median of 0.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (DOCMF) is currently considered Fairly Valued. The stock's GF Value™ is $0.97, compared to a current price of $0.97 — trading right at its estimated fair value. The current Equity-to-Asset is 0.41, which is near median its 10-year median of 0.38 and 25.5% below the Manufacturing - Apparel & Accessories industry median of 0.55. Dr. Martens' overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Dr. Martens (DOCMF), the current Equity-to-Asset is 0.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr. Martens (DOCMF) Overvalued in 2026?
Based on GuruFocus' analysis, Dr. Martens stock appears to be undervalued.
The current stock price of $0.97 is trading 0% below its estimated GF Value™ of $0.97.
GuruFocus considers Dr. Martens to be Fairly Valued.
Key valuation signals for DOCMF:
Equity-to-Asset: 0.41 (near median its 10-year median of 0.38)
GF Value™: $0.97 vs. price of $0.97 (0% below fair value)
Industry Position: 25.5% below the Manufacturing - Apparel & Accessories median (#733 of 1060)
No single metric tells the full story. See the DOCMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
55GF Score
Get the complete analysis for DOCMF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DOCMF has been successfully added to your 
